Preparation of La Crosse virus hemagglutinating antigen in BHK-21 suspension cell cultures.
D000818:Animals; D000917:Antibody Formation; D000941:Antigens / Q000096:biosynthesis*; D001103:Arboviruses / Q000187:drug effects / Q000276:immunology*; D001921:Brain; D002460:Cell Line; D003168:Complement Fixation Tests; D006224:Cricetinae; D003470:Culture Media; D046508:Culture Techniques; D004355:Drug Stability; D005612:Freeze Drying; D006385:Hemagglutination Inhibition Tests; D006386:Hemagglutination Tests; D006389:Hemagglutinins, Viral; D006801:Humans; D007668:Kidney; D007783:Lactones / Q000494:pharmacology; D051379:Mice; D011422:Propionates / Q000494:pharmacology; D013501:Surface-Active Agents / Q000494:pharmacology
D000941:Antigens; D003470:Culture Media; D006389:Hemagglutinins, Viral; D007783:Lactones; D011422:Propionates; D013501:Surface-Active Agents